ATNM
Actinium Pharmaceuticals Inc
1.10$
+1.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.5% | +8.5% | -12.5% | +6.9% | +1.0% | +0.5% | -0.5% | +1.0% | +0.0% | +6.8% | +9.5% | – | |
| – | +0.7% | +48.7% | -0.3% | -2.7% | -10.0% | +637.7% | -97.8% | -44.7% | -90.8% | +10.0% | +972.7% | – | |
| – | -31.3% | -142.1% | – | -207.0% | – | – | – | -239.1% | – | -233.1% | – | – | |
| – | -100.0% | – | -100.0% | – | – | – | – | – | – | -98.1% | +23,800.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -98.1% | +23,800.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | +50.0% | -33.3% | +50.0% | +0.0% | -33.3% | – | |
| – | -58.3% | +1,138.9% | -32.6% | -53.8% | -100.1% | -33.3% | +50.0% | +6,866.7% | -98.6% | +0.0% | -33.3% | – | |
| – | – | – | -73.2% | -472.6% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.